Aim: This study aimed to demonstrate the feasibility of identifying candidates of portopulmonary hypertension (PoPH) from general portal hypertension patients based on chest computed tomography (CT) results. Methods: One hundred and thirty patients with portal hypertension who had undergone interventional radiology therapies at our hospital between August 2011 and July 2021 were included, and preoperative clinical data were collected. Suspicious PoPH was defined as main pulmonary artery diameter (mPA-D) ≥ 29 mm or the ratio of mPA-D to ascending aorta diameter (mPA-D/aAo-D) ≥ 1.0, and probable PoPH as mPA-D ≥ 33 mm based on the chest CT. Prevalence of suspicious and probable PoPH was evaluated, and the differences in clinical characteristics of each population were compared.Results: Overall, 29 (22.3%) and 5 (3.8%) patients were categorized as suspicious and probable PoPH, respectively. Univariate analyses revealed that female sex, higher shortest diameter of inferior vena cava, presence of portosystemic shunts ≥ 5 mm, and lower blood urea nitrogen levels were significantly associated with suspicious PoPH (p < 0.05). Multivariate analyses identified all four factors as significantly independent determinants of suspicious PoPH (p < 0.05). In addition, among the population of suspicious PoPH, there were significant differences in seven parameters, including total bilirubin levels and spleen volume between patients with and without probable PoPH (p < 0.05). However, no significant independent indicators of probable PoPH were found.
Conclusions: CT-based measurements of mPA-D and mPA-D/aAo-D have the potential to screen patients with suspicious PoPH in clinical practice focused on portal hypertension.Abbreviations: aAo-D, ascending aorta diameter; ALBI, albumin-bilirubin; APRI, aspartate aminotransferase-to-platelet ratio index; AUROC, area under the receiver operating characteristic; BNP, brain natriuretic peptide; BUN, blood urea nitrogen; CP, Child-Pugh; CT, computed tomography; HVPG, hepatic venous pressure gradient; IVC-LD, longest diameter of inferior vena cava; IV-COL-7S, 7S domain of type IV collagen; IVC-SD, shortest diameter of inferior vena cava; MELD, Model for End-Stage Liver Disease; MELD-Na, Model for End-Stage Liver Diseasesodium; mPA-D, main pulmonary artery diameter; mPA-D/aAo-D, ratio of main pulmonary artery diameter to ascending aorta diameter; mPAP, mean pulmonary arterial pressure; PAH, pulmonary arterial hypertension; PAP, pulmonary arterial pressure; PoPH, portopulmonary hypertension; PSS, portosystemic shunt; PV, portal vein; RHC, right heart catheterization; ROC, receiver operating characteristic; SpV, splenic vein.